PLRX
Pliant Therapeutics Inc
NASDAQ: PLRX · HEALTHCARE · BIOTECHNOLOGY
$1.21
+0.00% today
Updated 2026-04-29
Market cap
$74.92M
P/E ratio
—
P/S ratio
3,071.82x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Pliant Therapeutics Inc (PLRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |